Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-034087
Filing Date
2026-05-12
Accepted
2026-05-12 16:04:10
Documents
1
Period of Report
2026-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1778616247.html 4  
1 FORM 4 wk-form4_1778616247.xml 4 4054
  Complete submission text file 0001628280-26-034087.txt   5501
Mailing Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BICARA THERAPEUTICS INC. 116 HUNTINGTON AVE, SUITE 703 BOSTON MA 02116
Business Address
Schelman William (Reporting) CIK: 0002132269 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 26968363